{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:52:45Z","timestamp":1721479965728},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,11]]},"DOI":"10.7759\/cureus.14951","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T10:32:02Z","timestamp":1620729122000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapid and Durable Response With Nab-Sirolimus After Everolimus Failure in a Patient With Perivascular Epithelioid Cell Tumors (PEComas) of the Uterus"],"prefix":"10.7759","author":[{"given":"Pallavi","family":"Kopparthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0509-1","article-title":"PEComas: the past, the present and the future","author":"Martignoni G","year":"2008","unstructured":"Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008. 452:119-32. 10.1007\/s00428-007-0509-1"},{"key":"ref2","article-title":"Activation of the mTOR pathway in sporadic angiomyolipomas and other epithelioid cell neoplasms","volume":"38","author":"Kenerson H","year":"2007","unstructured":"Kenerson H, Folpe AL, Takayama TK, et al.. Activation of the mTOR pathway in sporadic angiomyolipomas and other epithelioid cell neoplasms. Hum Pathol. 2007, 38:1361-71. 0.1016\/j.humpath.2007.01.028","journal-title":"Hum Pathol"},{"key":"ref3","article-title":"Weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (EComa): results from AMPECT, an open-label phase 2 registration trial with independent radiology review","volume":"3206452","author":"Dickson M","year":"2019","unstructured":"Dickson M, Ravi V, Riedel F, et al.. Weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (EComa): results from AMPECT, an open-label phase 2 registration trial with independent radiology review. CTOS Annual Meeting. 2019, 3206452:","journal-title":"CTOS Annual Meeting"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7800-5-7","article-title":"Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm","volume":"5","author":"Fadare O","year":"2008","unstructured":"Fadare O. Uterine PEComa: appraisal of a controversial and increasingly reported mesenchymal neoplasm. Int Semin Surg Oncol. 2008, 5:7. 10.1186\/1477-7800-5-7","journal-title":"Int Semin Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90618-z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"The European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993, 75:1305-15. 10.1016\/0092-8674(93)90618-z","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/9783527630073","article-title":"","author":"Kwiatkowski DJ","year":"2010","unstructured":"Kwiatkowski DJ, Thiele EA, Whittemore VH. Tuberous Sclerosis Complex. Wiley-VCH, Weinheim, Germany; 2010. 10.1002\/9783527630073"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.01.028","article-title":"Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms","volume":"38","author":"Kenerson H","year":"2007","unstructured":"Kenerson H, Folpe AL, Takayama TK, Yeung RS. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol. 2007, 38:1361-71. 10.1016\/j.humpath.2007.01.028","journal-title":"Hum Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"Pan CC","year":"2008","unstructured":"Pan CC, Chung MY, Ng KF, et al.. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol. 2008, 214:387-93. 10.1002\/path.2289","journal-title":"J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31824a8a37","article-title":"Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction","volume":"36","author":"Malinowska I","year":"2012","unstructured":"Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol. 2012, 36:783-4. 10.1097\/PAS.0b013e31824a8a37","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3110","article-title":"Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial","volume":"19","author":"Gonzalez-Angulo AM","year":"2013","unstructured":"Gonzalez-Angulo AM, Meric-Bernstam F, Chawla S, et al.. Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. Clin Cancer Res. 2013, 19:5474-84. 10.1158\/1078-0432.CCR-12-3110","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2019-3896","article-title":"Distinct pharmacokinetics, tissue distribution and CNS penetration of ABI-009 (nab-sirolimus)","volume":"79","author":"Hou S","year":"2019","unstructured":"Hou S, Schmid A, Desai N. Distinct pharmacokinetics, tissue distribution and CNS penetration of ABI-009 (nab-sirolimus). AACR. 2019, 79:3896. 10.1158\/1538-7445.AM2019-3896","journal-title":"AACR"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51102-rapid-and-durable-response-with-nab-sirolimus-after-everolimus-failure-in-a-patient-with-perivascular-epithelioid-cell-tumors-pecomas-of-the-uterus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:05Z","timestamp":1707506825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51102-rapid-and-durable-response-with-nab-sirolimus-after-everolimus-failure-in-a-patient-with-perivascular-epithelioid-cell-tumors-pecomas-of-the-uterus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.14951","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}